rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Senti Biosciences Holdings, Inc.

SNTI · Nasdaq

Health CareBiotechnologyNot moving yet

SNTI stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 67.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
17 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$24K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders17+3 on the quarter
New · exited5 · 2
Reported value$5.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
NEA Management Company, LLCunchanged · filed 14 Aug 20263,775,615$4.2M00.0%
VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026537,504$591K00.0%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026187,065$206K-19,978−9.6%
CITADEL ADVISORS LLCnew · filed 14 Aug 2026107,100$118K+107,100
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 202691,193$100K00.0%
JANE STREET GROUP, LLCnew · filed 14 Aug 202652,530$58K+52,530
Menlo Ventures Management, L.P.unchanged · filed 10 Aug 202635,737$39K00.0%
NORTHERN TRUST CORPadded · filed 13 Aug 202632,154$35K+15,376+91.6%
XTX Topco Ltdadded · filed 14 Aug 202623,610$26K+6,333+36.7%
UBS Group AGadded · filed 13 Aug 202614,432$16K+5,795+67.1%
30 Sep 2024 – 30 Jun 2026
111417Sep 24Mar 25Sep 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Kanya Rajangam Company insiderPres. & Chief Med. & Dev. Off. · last 9 Mar 20260 · 2
Timothy K. Lu Company insiderCEO · last 9 Mar 20260 · 2
Bryan Daniel Baum Company insiderDirector · last 18 Jul 20250 · 0
Brenda Cooperstone Company insiderDirector · last 25 Jun 20250 · 0
Donald F. Tang Company insiderDirector · last 25 Jun 20250 · 0
Edward T. Mathers Company insiderDirector · last 25 Jun 20250 · 0
Feng Hsiung Company insiderDirector · last 25 Jun 20250 · 0
Fran Schulz Company insiderDirector · last 25 Jun 20250 · 0
James J. Collins Company insiderDirector · last 25 Jun 20250 · 0
Anthony A. Florence Jr. Company insider10% owner · last 10 Mar 20250 · 0
Bayer Us Holding Lp Company insider10% owner · last 10 Mar 20250 · 0
Celadon Partners Spv 24 Company insider10% owner · last 10 Mar 20250 · 0

Same industry

MRNA ModernaLeading+147%
IOVA Iovance BiotherapeuticsLeading+126%
ABCL AbCellera BiologicsLeading+60%
HALO Halozyme TherapeuticsLeading+46%
XERS Xeris Biopharma HoldingsLeading+38%
ENTX Entera BioLeading+37%
HELP Helus PharmaLeading+36%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-185%
Share count trendFY 2025 · to 19 Mar 20260.9%
Cash and equivalentsFY 2025 · to 31 Dec 2025$16.4M
Free cash flowFY 2025 · to 31 Dec 2025−$43.6M

Analyst forecasts

No analyst forecasts yet.